Skip to main content

treprostinil

Generic: TREPROSTINIL·Brand: Orenitram, REMODULIN, Remodulin, TREPROSTINIL, TYVASO, TYVASO DPI, Tyvaso, YUTREPIA

treprostinil: sourced relationships with 2 companies · 2 clinical trials tracked · 1 FDA decision.

treprostinil evidence translation

What we can confirm

1 FDA record · 2 tracked trials

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about treprostinil, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 0 study sponsors

Related indications

Pulmonary arterial hypertension (PAH)Delayed Graft FunctionInterstitial Lung DiseasePulmonary Arterial Hypertension

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (2)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2020-05-22 · Current development: unknownSource
Approved
UNITED THERAPEUTICS Corp (UTHR)
developer · Reported 2024-02-21 · Current development: unknownSource
Pulmonary arterial hypertension (PAH)
Approved
Clinical Trial Registry Records (2)

Comprehensive O2 Transfer Analysis From the Lung to Mitochondria of Inhaled Treprostinil in Interstitial Lung Disease Pulmonary Hypertension

NCT05564637Registry updated 2025-12-03·Phase 2
Completed

Primary endpoint: Cardiac Output Reserve (Qc)

Interventionalopen29 enrolledStarted 2023-03Completion 2024-101 site · United StatesMayo Clinic

A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation

NCT04005469Registry updated 2026-04-23·Phase 1/Phase 2
Recruiting

Primary endpoint: Serum creatinine (SCr)

Interventionalopen20 targetStarted 2020-11Completion 2028-061 site · United StatesRhode Island Hospital
FDA Decisions1 records
Approval(RDY)FDA ↗
ANDA210214UNKNOWNStandardIntravenousInjectable

Frequently asked questions

Which companies have sourced relationships with treprostinil?

treprostinil has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD, UNITED THERAPEUTICS Corp.

How many clinical trials involve treprostinil?

BioSniper tracks 2 clinical trials involving treprostinil.

What is treprostinil's latest FDA decision?

The most recent tracked FDA decision for treprostinil is Approval, dated May 22, 2020.